MMSET is dynamically regulated during cell-cycle progression and promotes normal DNA replication

References

• Blow JJ, Gillespie PJ. Replication licensing and cancer–a fatal entanglement? Nat Rev Cancer 2008; 8:799–806; PMID:18756287; http://dx.doi.org/10.1038/nrc2500
   PubMed Web of Science ®Google Scholar
• Mendez J, Stillman B. Perpetuating the double helix: molecular machines at eukaryotic DNA replication origins. BioEssays 2003; 25:1158–67; PMID:14635251; http://dx.doi.org/10.1002/bies.10370
   PubMed Web of Science ®Google Scholar
• Blow JJ, Dutta A. Preventing re-replication of chromosomal DNA. Nat Rev Mol Cell Biol 2005; 6:476–86; PMID:15928711; http://dx.doi.org/10.1038/nrm1663
   PubMed Web of Science ®Google Scholar
• Arias EE, Walter JC. Strength in numbers: preventing rereplication via multiple mechanisms in eukaryotic cells. Gen Dev 2007; 21:497–518; PMID:17344412; http://dx.doi.org/10.1101/gad.1508907
   PubMed Web of Science ®Google Scholar
• Moyer SE, Lewis PW, Botchan MR. Isolation of the Cdc45/Mcm2-7/GINS (CMG) complex, a candidate for the eukaryotic DNA replication fork helicase. Proc Natl Acad Sci U S A 2006; 103:10236–41; PMID:16798881; http://dx.doi.org/10.1073/pnas.0602400103
   PubMed Web of Science ®Google Scholar
• Ilves I, Petojevic T, Pesavento JJ, Botchan MR. Activation of the MCM2-7 helicase by association with Cdc45 and GINS proteins. Mol Cell 2010; 37:247–58; PMID:20122406; http://dx.doi.org/10.1016/j.molcel.2009.12.030
   PubMed Web of Science ®Google Scholar
• Moldovan GL, Pfander B, Jentsch S. PCNA, the maestro of the replication fork. Cell 2007; 129:665–79; PMID:17512402; http://dx.doi.org/10.1016/j.cell.2007.05.003
   PubMed Web of Science ®Google Scholar
• Wohlschlegel JA, Dwyer BT, Dhar SK, Cvetic C, Walter JC, Dutta A. Inhibition of eukaryotic DNA replication by geminin binding to Cdt1. Science 2000; 290:2309–12; PMID:11125146; http://dx.doi.org/10.1126/science.290.5500.2309
   PubMed Web of Science ®Google Scholar
• Tada S, Li A, Maiorano D, Mechali M, Blow JJ. Repression of origin assembly in metaphase depends on inhibition of RLF-B/Cdt1 by geminin. Nat Cell Biol 2001; 3:107–13; PMID:11175741; http://dx.doi.org/10.1038/35055000
   PubMed Web of Science ®Google Scholar
• Li X, Zhao Q, Liao R, Sun P, Wu X. The SCF(Skp2) ubiquitin ligase complex interacts with the human replication licensing factor Cdt1 and regulates Cdt1 degradation. J Biol Chem 2003; 278:30854–8; PMID:12840033; http://dx.doi.org/10.1074/jbc.C300251200
   PubMed Web of Science ®Google Scholar
• Havens CG, Walter JC. Mechanism of CRL4(Cdt2), a PCNA-dependent E3 ubiquitin ligase. Gen Dev 2011; 25:1568–82; PMID:21828267; http://dx.doi.org/10.1101/gad.2068611
   PubMed Web of Science ®Google Scholar
• Jin J, Arias EE, Chen J, Harper JW, Walter JC. A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1. Mol Cell 2006; 23:709–21; PMID:16949367; http://dx.doi.org/10.1016/j.molcel.2006.08.010
   PubMed Web of Science ®Google Scholar
• Lee J, Zhou P. DCAFs, the missing link of the CUL4-DDB1 ubiquitin ligase. Mol Cell 2007; 26:775–80; PMID:17588513; http://dx.doi.org/10.1016/j.molcel.2007.06.001
   PubMed Web of Science ®Google Scholar
• O'Connell BC, Harper JW. Ubiquitin proteasome system (UPS): what can chromatin do for you?. Curr Opin Cell Biol 2007; 19:206–14; PMID:17314036; http://dx.doi.org/10.1016/j.ceb.2007.02.014
   PubMed Web of Science ®Google Scholar
• Arias EE, Walter JC. PCNA functions as a molecular platform to trigger Cdt1 destruction and prevent re-replication. Nat Cell Biol 2006; 8:84–90; PMID:16362051; http://dx.doi.org/10.1038/ncb1346
   PubMed Web of Science ®Google Scholar
• Zhong W, Feng H, Santiago FE, Kipreos ET. CUL-4 ubiquitin ligase maintains genome stability by restraining DNA-replication licensing. Nature 2003; 423:885–9; PMID:12815436; http://dx.doi.org/10.1038/nature01747
   PubMed Web of Science ®Google Scholar
• Abbas T, Sivaprasad U, Terai K, Amador V, Pagano M, Dutta A. PCNA-dependent regulation of p21 ubiquitylation and degradation via the CRL4Cdt2 ubiquitin ligase complex. Gen Dev 2008; 22:2496–506; PMID:18794347; http://dx.doi.org/10.1101/gad.1676108
   PubMed Web of Science ®Google Scholar
• Nishitani H, Lygerou Z, Nishimoto T. Proteolysis of DNA replication licensing factor Cdt1 in S-phase is performed independently of geminin through its N-terminal region. J Biol Chem 2004; 279:30807–16; PMID:15138268; http://dx.doi.org/10.1074/jbc.M312644200
   PubMed Web of Science ®Google Scholar
• Nishitani H, Shiomi Y, Iida H, Michishita M, Takami T, Tsurimoto T. CDK inhibitor p21 is degraded by a proliferating cell nuclear antigen-coupled Cul4-DDB1Cdt2 pathway during S phase and after UV irradiation. J Biol Chem 2008; 283:29045–52; PMID:18703516; http://dx.doi.org/10.1074/jbc.M806045200
   PubMed Web of Science ®Google Scholar
• Tardat M, Brustel J, Kirsh O, Lefevbre C, Callanan M, Sardet C, Julien E. The histone H4 Lys 20 methyltransferase PR-Set7 regulates replication origins in mammalian cells. Nat Cell Biol 2010; 12:1086–93; PMID:20953199; http://dx.doi.org/10.1038/ncb2113
   PubMed Web of Science ®Google Scholar
• Sansam CL, Shepard JL, Lai K, Ianari A, Danielian PS, Amsterdam A, Hopkins N, Lees JA. DTLCDT2 is essential for both CDT1 regulation and the early G21487;M checkpoint. Gen Dev 2006; 20:3117–29; PMID:17085480; http://dx.doi.org/10.1101/gad.1482106
   PubMed Web of Science ®Google Scholar
• Kim Y, Starostina NG, Kipreos ET. The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing. Gen Dev 2008; 22:2507–19; PMID:18794348; http://dx.doi.org/10.1101/gad.1703708
   PubMed Web of Science ®Google Scholar
• Lovejoy CA, Lock K, Yenamandra A, Cortez D. DDB1 maintains genome integrity through regulation of Cdt1. Mol Cell Biol 2006; 26:7977–90; PMID:16940174; http://dx.doi.org/10.1128/MCB.00819-06
   PubMed Web of Science ®Google Scholar
• Chesi M, Nardini E, Lim RS, Smith KD, Kuehl WM, Bergsagel PL. The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgHMMSET hybrid transcripts. Blood 1998; 92:3025–34; PMID:9787135
   PubMed Web of Science ®Google Scholar
• Keats JJ, Maxwell CA, Taylor BJ, Hendzel MJ, Chesi M, Bergsagel PL, Larratt LM, Mant MJ, Reiman T, Belch AR, et al. Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients. Blood 2005; 105:4060–9; PMID:15677557; http://dx.doi.org/10.1182/blood-2004-09-3704
   PubMed Web of Science ®Google Scholar
• Keats JJ, Reiman T, Belch AR, Pilarski LM. Ten years and counting: so what do we know about t(4;14)(p16;q32) multiple myeloma. Leukemia & lymphoma 2006; 47:2289–300; PMID:17107900; http://dx.doi.org/10.1080/10428190600822128
   PubMed Web of Science ®Google Scholar
• Keats JJ, Reiman T, Maxwell CA, Taylor BJ, Larratt LM, Mant MJ, Belch AR, Pilarski LM. In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression. Blood 2003; 101:1520–9; PMID:12393535; http://dx.doi.org/10.1182/blood-2002-06-1675
   PubMed Web of Science ®Google Scholar
• Santra M, Zhan F, Tian E, Barlogie B, Shaughnessy J, Jr. A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGHMMSET fusion transcript. Blood 2003; 101:2374–6; PMID:12433679; http://dx.doi.org/10.1182/blood-2002-09-2801
   PubMed Web of Science ®Google Scholar
• Kassambara A, Klein B, Moreaux J. MMSET is overexpressed in cancers: link with tumor aggressiveness. Biochem Biophys Res commun 2009; 379:840–5; PMID:19121287; http://dx.doi.org/10.1016/j.bbrc.2008.12.093
   PubMed Web of Science ®Google Scholar
• Hudlebusch HR, Santoni-Rugiu E, Simon R, Ralfkiaer E, Rossing HH, Johansen JV, Jorgensen M, Sauter G, Helin K. The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors. Clin Cancer Res; 17:2919–33; PMID:21385930; http://dx.doi.org/10.1158/1078-0432.CCR-10-1302
   PubMed Web of Science ®Google Scholar
• Hudlebusch HR, Skotte J, Santoni-Rugiu E, Zimling ZG, Lees MJ, Simon R, Sauter G, Rota R, De Ioris MA, Quarto M, et al. MMSET is highly expressed and associated with aggressiveness in neuroblastoma. Cancer Res 2011; 71:4226–35; PMID:21527557; http://dx.doi.org/10.1158/0008-5472.CAN-10-3810
   PubMed Web of Science ®Google Scholar
• Oyer JA, Huang X, Zheng Y, Shim J, Ezponda T, Carpenter Z, Allegretta M, Okot-Kotber CI, Patel JP, Melnick A, et al. Point mutation E1099K in MMSET(NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies. Leukemia 2014; 28:198–201; PMID:23823660; http://dx.doi.org/10.1038/leu.2013.204
   PubMed Web of Science ®Google Scholar
• Jaffe JD, Wang Y, Chan HM, Zhang J, Huether R, Kryukov GV, Bhang HE, Taylor JE, Hu M, Englund NP, et al. Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia. Nat Gen 2013; 45:1386–91; PMID:24076604; http://dx.doi.org/10.1038/ng.2777
   PubMed Web of Science ®Google Scholar
• Hirschhorn K, Cooper HL, Firschein IL. Deletion of short arms of chromosome 4-5 in a child with defects of midline fusion. Humangenetik 1965; 1:479–82; PMID:5895684
   PubMedGoogle Scholar
• Wright TJ, Clemens M, Quarrell O, Altherr MR. Wolf-Hirschhorn and Pitt-Rogers-Danks syndromes caused by overlapping 4p deletions. Am J Med Gen 1998; 75:345–50; PMID:9482639; http://dx.doi.org/10.1002/(SICI)1096-8628(19980203)75:4%3c345::AID-AJMG2%3e3.0.CO;2-P
   PubMed Web of Science ®Google Scholar
• Wright TJ, Ricke DO, Denison K, Abmayr S, Cotter PD, Hirschhorn K, Keinanen M, McDonald-McGinn D, Somer M, Spinner N, et al. A transcript map of the newly defined 165 kb Wolf-Hirschhorn syndrome critical region. Hum Mol Gen 1997; 6:317–24; PMID:9063753; http://dx.doi.org/10.1093/hmg/6.2.317
   PubMed Web of Science ®Google Scholar
• Stec I, Wright TJ, van Ommen GJ, de Boer PA, van Haeringen A, Moorman AF, Altherr MR, den Dunnen JT. WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma. Hum Mol Gen 1998; 7:1071–82; PMID:9618163; http://dx.doi.org/10.1093/hmg/7.7.1071
   PubMed Web of Science ®Google Scholar
• Bergemann AD, Cole F, Hirschhorn K. The etiology of Wolf-Hirschhorn syndrome. TrendsGen 2005; 21:188–95; PMID:15734578; http://dx.doi.org/10.1016/j.tig.2005.01.008
   PubMed Web of Science ®Google Scholar
• Nimura K, Ura K, Shiratori H, Ikawa M, Okabe M, Schwartz RJ, Kaneda Y. A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome. Nature 2009; 460:287–91; PMID:19483677; http://dx.doi.org/10.1038/nature08086
   PubMed Web of Science ®Google Scholar
• Ohtsubo M, Theodoras AM, Schumacher J, Roberts JM, Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Molecular and cellular biology 1995; 15:2612–24; PMID:7739542; http://dx.doi.org/10.1128/MCB.15.5.2612
   PubMed Web of Science ®Google Scholar
• Li Y, Jaramillo-Lambert A, Hao J, Yang Y, Zhu W. The stability of histone acetyltransferase general control non-derepressible (Gcn) 5 is regulated by Cullin4-RING E3 ubiquitin ligase. J Biol Chem 2011; 286:41344–52; PMID:21987584; http://dx.doi.org/10.1074/jbc.M111.290767
   PubMed Web of Science ®Google Scholar
• Huh J, Piwnica-Worms H. CRL4(CDT2) targets CHK1 for PCNA-independent destruction. Mol Cell Biol 2013; 33:213–26; PMID:23109433; http://dx.doi.org/10.1128/MCB.00847-12
   PubMed Web of Science ®Google Scholar
• Centore RC, Havens CG, Manning AL, Li JM, Flynn RL, Tse A, Jin J, Dyson NJ, Walter JC, Zou L. CRL4(Cdt2)-mediated destruction of the histone methyltransferase Set8 prevents premature chromatin compaction in S phase. Mol Cell 2010; 40:22–33; PMID:20932472; http://dx.doi.org/10.1016/j.molcel.2010.09.015
   PubMed Web of Science ®Google Scholar
• Marango J, Shimoyama M, Nishio H, Meyer JA, Min DJ, Sirulnik A, Martinez-Martinez Y, Chesi M, Bergsagel PL, Zhou MM, et al. The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor. Blood 2008; 111:3145–54; PMID:18156491; http://dx.doi.org/10.1182/blood-2007-06-092122
   PubMed Web of Science ®Google Scholar
• Brito JL, Walker B, Jenner M, Dickens NJ, Brown NJ, Ross FM, Avramidou A, Irving JA, Gonzalez D, Davies FE, et al. MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells. Haematologica 2009; 94:78–86; PMID:19059936; http://dx.doi.org/10.3324/haematol.13426
   PubMed Web of Science ®Google Scholar
• Martinez-Garcia E, Popovic R, Min DJ, Sweet SM, Thomas PM, Zamdborg L, Heffner A, Will C, Lamy L, Staudt LM, et al. The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells. Blood 2011; 117:211–20; PMID:20974671; http://dx.doi.org/10.1182/blood-2010-07-298349
   PubMed Web of Science ®Google Scholar
• Kuo AJ, Cheung P, Chen K, Zee BM, Kioi M, Lauring J, Xi Y, Park BH, Shi X, Garcia BA, et al. NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming. Mol cell 2011; 44:609–20; PMID:22099308; http://dx.doi.org/10.1016/j.molcel.2011.08.042
   PubMed Web of Science ®Google Scholar
• Toyokawa G, Cho HS, Masuda K, Yamane Y, Yoshimatsu M, Hayami S, Takawa M, Iwai Y, Daigo Y, Tsuchiya E, et al. Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway. Neoplasia 2011; 13:887–98; PMID:22028615; http://dx.doi.org/10.1593/neo.11048
   PubMed Web of Science ®Google Scholar
• Ezponda T, Popovic R, Shah MY, Martinez-Garcia E, Zheng Y, Min DJ, Will C, Neri A, Kelleher NL, Yu J, et al. The histone methyltransferase MMSETWHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer. Oncogene 2013; 32:2882–90; PMID:22797064; http://dx.doi.org/10.1038/onc.2012.297
   PubMed Web of Science ®Google Scholar
• Jorgensen S, Elvers I, Trelle MB, Menzel T, Eskildsen M, Jensen ON, Helleday T, Helin K, Sorensen CS. The histone methyltransferase SET8 is required for S-phase progression. J Cell Biol 2007; 179:1337–45; PMID:18166648; http://dx.doi.org/10.1083/jcb.200706150
   PubMed Web of Science ®Google Scholar
• Prasanth SG, Prasanth KV, Siddiqui K, Spector DL, Stillman B. Human Orc2 localizes to centrosomes, centromeres and heterochromatin during chromosome inheritance. EMBO J 2004; 23:2651–63; PMID:15215892; http://dx.doi.org/10.1038/sj.emboj.7600255
   PubMed Web of Science ®Google Scholar
• Prasanth SG, Prasanth KV, Stillman B. Orc6 involved in DNA replication, chromosome segregation, and cytokinesis. Science 2002; 297:1026–31; PMID:12169736; http://dx.doi.org/10.1126/science.1072802
   PubMed Web of Science ®Google Scholar
• Miotto B, Struhl K. HBO1 histone acetylase activity is essential for DNA replication licensing and inhibited by Geminin. Mol Cell 2010; 37:57–66; PMID:20129055; http://dx.doi.org/10.1016/j.molcel.2009.12.012
   PubMed Web of Science ®Google Scholar
• Sugimoto N, Yugawa T, Iizuka M, Kiyono T, Fujita M. Chromatin remodeler sucrose nonfermenting 2 homolog (SNF2H) is recruited onto DNA replication origins through interaction with Cdc10 protein-dependent transcript 1 (Cdt1) and promotes pre-replication complex formation. J Biol Chem 2011; 286:39200–10; PMID:21937426; http://dx.doi.org/10.1074/jbc.M111.256123
   PubMed Web of Science ®Google Scholar
• Kuo AJ, Song J, Cheung P, Ishibe-Murakami S, Yamazoe S, Chen JK, Patel DJ, Gozani O. The BAH domain of ORC1 links H4K20me2 to DNA replication licensing and Meier-Gorlin syndrome. Nature 2012; 484:115–9; PMID:22398447; http://dx.doi.org/10.1038/nature10956
   PubMed Web of Science ®Google Scholar
• Rice JC, Nishioka K, Sarma K, Steward R, Reinberg D, Allis CD. Mitotic-specific methylation of histone H4 Lys 20 follows increased PR-Set7 expression and its localization to mitotic chromosomes. Gen Dev 2002; 16:2225–30; PMID:12208845; http://dx.doi.org/10.1101/gad.1014902
   PubMed Web of Science ®Google Scholar
• Tardat M, Murr R, Herceg Z, Sardet C, Julien E. PR-Set7-dependent lysine methylation ensures genome replication and stability through S phase. J Cell Biol 2007; 179:1413–26; PMID:18158331; http://dx.doi.org/10.1083/jcb.200706179
   PubMed Web of Science ®Google Scholar
• Xu H, Zhang P, Liu L, Lee MY. A novel PCNA-binding motif identified by the panning of a random peptide display library. Biochem 2001; 40:4512–20; PMID:11284708; http://dx.doi.org/10.1021/bi010103+
   PubMed Web of Science ®Google Scholar
• Kerzendorfer C, Colnaghi R, Abramowicz I, Carpenter G, O'Driscoll M. Meier-Gorlin syndrome and Wolf-Hirschhorn syndrome: two developmental disorders highlighting the importance of efficient DNA replication for normal development and neurogenesis. DNA Repair 2013; 12:637–44; PMID:23706772; http://dx.doi.org/10.1016/j.dnarep.2013.04.016
   PubMed Web of Science ®Google Scholar
• Kerzendorfer C, Hannes F, Colnaghi R, Abramowicz I, Carpenter G, Vermeesch JR, O'Driscoll M. Characterizing the functional consequences of haploinsufficiency of NELF-A (WHSC2) and SLBP identifies novel cellular phenotypes in Wolf-Hirschhorn syndrome. Human molecular genetics 2012; 21:2181–93; PMID:22328085; http://dx.doi.org/10.1093/hmg/dds033
   PubMed Web of Science ®Google Scholar
• Deng M, Li F, Ballif BA, Li S, Chen X, Guo L, Ye X. Identification and functional analysis of a novel cyclin e/cdk2 substrate ankrd17. J Biol Chem 2009; 284:7875–88; PMID:19150984; http://dx.doi.org/10.1074/jbc.M807827200
   PubMed Web of Science ®Google Scholar
• Braden WA, Lenihan JM, Lan Z, Luce KS, Zagorski W, Bosco E, Reed MF, Cook JG, Knudsen ES. Distinct action of the retinoblastoma pathway on the DNA replication machinery defines specific roles for cyclin-dependent kinase complexes in prereplication complex assembly and S-phase progression. Mol Cell Biol 2006; 26:7667–81; PMID:16908528; http://dx.doi.org/10.1128/MCB.00045-06
   PubMed Web of Science ®Google Scholar
• Ham H, Guerrier S, Kim J, Schoon RA, Anderson EL, Hamann MJ, Lou Z, Billadeau DD. Dedicator of cytokinesis 8 interacts with talin and Wiskott-Aldrich syndrome protein to regulate NK cell cytotoxicity. J Immunol 2013; 190:3661–9; http://dx.doi.10.4049/jimmunol.1202792
   PubMed Web of Science ®Google Scholar
• Yanagiya A, Suyama E, Adachi H, Svitkin YV, Aza-Blanc P, Imataka H, Mikami S, Martineau Y, Ronai ZA, Sonenberg N. Translational homeostasis via the mRNA cap-binding protein, eIF4E. Mol Cell 2012; 46:847–58; PMID:22578813; http://dx.doi.org/10.1016/j.molcel.2012.04.004
   PubMed Web of Science ®Google Scholar